New Zealand shares fell, led lower by Oceania Healthcare after it reported annual earnings significantly weaker due to covid-19.

New Zealand shares edged lower as the two biggest companies - Fisher & Paykel Healthcare and A2 Milk - weighed on the broader index, following Australia lower amid concerns over the latest wave of new covid-19 cases across the Tasman.

[UPDATED] New Zealand shares jumped on growing optimism among investors that US tech companies will deliver strong earnings in the current earnings season and that potential covid-19 vaccine trials are showing promise. (Corrected Heartland guidance).

New Zealand shares fell as a global spike in coronavirus cases kept the risk of further economic disruption on investors’ minds.

New Zealand shares rose as the local economy's relatively strong recovery from the covid-19 lockdown attracted investors keen to limit their exposure to the likes of Australia and the US, where the virus is spreading once more.

New Zealand shares snapped a three-day rally, as investors grew concerned about deteriorating US-China relations and the economic cost of a resurgence of covid-19.

New Zealand shares rose for a third day as investors welcomed interim results of a covid-19 vaccine trial which showed a positive immune response to the virus.

New Zealand shares rose as investors sought property stocks paying reliable dividends amid concerns over the covid-19 pandemic and heightened tensions between the US and China.

New Zealand shares joined a rally across Asia, as upbeat investor sentiment spilled over from Wall Street's close on Friday on optimism over a late-stage trial for a hopeful covid-19 treatment.

New Zealand shares fell as energy stocks declined for a second day following the announcement Rio Tinto’s New Zealand aluminium smelter will close.

New Zealand shares slumped, led by a sharp drop across the energy sector after Rio Tinto said it will close the Tiwai Point aluminium smelter next year, having given notice to its supplier Meridian Energy.

New Zealand shares followed Australia lower as investors weighed up the economic impact of a covid-19 lockdown being re-imposed in the state of Victoria, where new cases of the coronavirus have spiked in the last week.

New Zealand shares rose for a fourth day as investors bet that further central bank stimulus and ongoing low interest rates will continue to support equities.

New Zealand shares rose, led by Metlifecare after the retirement village operator received a new takeover offer from its on-again, off-again suitor, EQT.

New Zealand shares rallied to a four-month high as some investors were encouraged by better-than-expected US jobs data and continued central bank support.

New Zealand shares rose as promising results from a covid-19 vaccine trial spurred optimistic investors to take positions in riskier stocks. Kathmandu Holdings led the market higher.